Raras
Buscar doenças, sintomas, genes...
Síndrome de encefalopatia-miocardiopatia hipertrófica-doença tubular renal
ORPHA:319678CID-10 · E88.8CID-11 · 5C53.22OMIM 614654DOENÇA RARA

É uma síndrome rara que afeta o cérebro, faz o coração ficar maior que o normal e causa problemas nos túbulos dos rins. É uma doença das mitocôndrias (as 'usinas de energia' das células) causada por um defeito na produção da coenzima Q10. A doença se manifesta com uma grande variedade de sinais e sintomas, que podem incluir: acúmulo excessivo de ácido láctico no sangue de recém-nascidos (acidose láctica), atraso global no desenvolvimento (físico e mental), alterações no tônus muscular (os músculos podem estar muito tensos ou muito 'moles'), convulsões, diminuição dos movimentos espontâneos (aqueles feitos sem esforço), aumento das paredes dos ventrículos (câmaras do coração), batimentos cardíacos lentos, mau funcionamento dos túbulos dos rins com grande eliminação de ácido láctico na urina, um defeito grave na parte da 'máquina' de energia das células chamada cadeia respiratória (nos complexos II e III, quando testados juntos) e falta de coenzima Q10 nos músculos do corpo. Na ressonância magnética, pode-se observar atrofia (diminuição de tamanho) no cérebro e no cerebelo (outra parte do cérebro). E, no ultrassom, foram notados vários cistos (pequenas bolsas de líquido) no plexo coroide (uma estrutura dentro do cérebro) e alterações simétricas que aparecem mais claras nos gânglios da base (outra região cerebral).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

É uma síndrome rara que afeta o cérebro, faz o coração ficar maior que o normal e causa problemas nos túbulos dos rins. É uma doença das mitocôndrias (as 'usinas de energia' das células) causada por um defeito na produção da coenzima Q10. A doença se manifesta com uma grande variedade de sinais e sintomas, que podem incluir: acúmulo excessivo de ácido láctico no sangue de recém-nascidos (acidose láctica), atraso global no desenvolvimento (físico e mental), alterações no tônus muscular (os músculos podem estar muito tensos ou muito 'moles'), convulsões, diminuição dos movimentos espontâneos (aqueles feitos sem esforço), aumento das paredes dos ventrículos (câmaras do coração), batimentos cardíacos lentos, mau funcionamento dos túbulos dos rins com grande eliminação de ácido láctico na urina, um defeito grave na parte da 'máquina' de energia das células chamada cadeia respiratória (nos complexos II e III, quando testados juntos) e falta de coenzima Q10 nos músculos do corpo. Na ressonância magnética, pode-se observar atrofia (diminuição de tamanho) no cérebro e no cerebelo (outra parte do cérebro). E, no ultrassom, foram notados vários cistos (pequenas bolsas de líquido) no plexo coroide (uma estrutura dentro do cérebro) e alterações simétricas que aparecem mais claras nos gânglios da base (outra região cerebral).

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
1
pacientes catalogados
Início
Neonatal
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: E88.8
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
9 sintomas
💪
Músculos
2 sintomas
❤️
Coração
2 sintomas
📏
Crescimento
2 sintomas
🫁
Pulmão
1 sintomas

+ 8 sintomas em outras categorias

Características mais comuns

100%prev.
Atrofia cerebelar
Obrigatório (100%)
100%prev.
Nível de coenzima Q10 diminuído no músculo esquelético
Obrigatório (100%)
100%prev.
Hipertrofia do ventrículo esquerdo
Obrigatório (100%)
100%prev.
Hipotermia
Obrigatório (100%)
100%prev.
Distonia
Obrigatório (100%)
100%prev.
Dificuldades alimentares
Obrigatório (100%)
24sintomas
Muito frequente (13)
Sem dados (11)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 24 características clínicas mais associadas, ordenadas por frequência.

Atrofia cerebelarCerebellar atrophy
Obrigatório (100%)100%
Nível de coenzima Q10 diminuído no músculo esqueléticoDecreased level of coenzyme Q10 in skeletal muscle
Obrigatório (100%)100%
Hipertrofia do ventrículo esquerdoLeft ventricular hypertrophy
Obrigatório (100%)100%
HipotermiaHypothermia
Obrigatório (100%)100%
DistoniaDystonia
Obrigatório (100%)100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Últimos 10 anos200publicações
Pico2025128 papers
Linha do tempo
2026Hoje · 2026🧪 2010Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

2 genes identificados com associação a esta condição. Padrão de herança: Autosomal recessive.

COQ7NADPH-dependent 3-demethoxyubiquinone 3-hydroxylase, mitochondrialDisease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Catalyzes the hydroxylation of the 5-methoxy-2-methyl-3-(all-trans-polyprenyl)benzoquinone at the C6 position and participates in the biosynthesis of ubiquinone (Probable). Catalyzes the reaction through a substrate-mediated reduction pathway, whereby NADH shuttles electrons to 5-methoxy-2-methyl-3-(all-trans-decaprenyl)benzoquinone, which then transfers the electrons to the two Fe(3+) centers (PubMed:23445365). The binding of 5-methoxy-2-methyl-3-(all-trans-polyprenyl)benzoquinone (DMQn) mediat

LOCALIZAÇÃO

Mitochondrion inner membraneMitochondrionNucleusChromosome

VIAS BIOLÓGICAS (1)
Ubiquinol biosynthesis
MECANISMO DE DOENÇA

Coenzyme Q10 deficiency, primary, 8

An autosomal recessive disorder resulting from mitochondrial dysfunction and characterized by decreased levels of coenzyme Q10. Patients manifest neonatal lung hypoplasia, contractures, early infantile hypertension and cardiac hypertrophy, secondary to prenatal kidney dysplasia, with neonatal and infantile renal dysfunction. Clinical features also include progressive peripheral neuropathy, muscular hypotonia and atrophy, and mild psychomotor delay with hearing and visual impairment.

VIAS REACTOME (1)
OUTRAS DOENÇAS (4)
primary coenzyme Q10 deficiency 8neuronopathy, distal hereditary motor, autosomal recessive 9encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndromeCOQ7-related distal hereditary motor neuropathy
HGNC:2244UniProt:Q99807
COQ9Ubiquinone biosynthesis protein COQ9, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Membrane-associated protein that warps the membrane surface to access and bind aromatic isoprenes with high specificity, including ubiquinone (CoQ) isoprene intermediates and presents them directly to COQ7, therefore facilitating the COQ7-mediated hydroxylase step (PubMed:25339443, PubMed:30661980, PubMed:38425362). Participates in the biosynthesis of coenzyme Q, also named ubiquinone, an essential lipid-soluble electron transporter for aerobic cellular respiration (PubMed:25339443, PubMed:30661

LOCALIZAÇÃO

Mitochondrion

VIAS BIOLÓGICAS (1)
Ubiquinol biosynthesis
MECANISMO DE DOENÇA

Coenzyme Q10 deficiency, primary, 5

A form of coenzyme Q10 deficiency, an autosomal recessive disorder with variable manifestations consistent with 5 major phenotypes. The phenotypes include an encephalomyopathic form with seizures and ataxia; a multisystem infantile form with encephalopathy, cardiomyopathy and renal failure; a predominantly cerebellar form with ataxia and cerebellar atrophy; Leigh syndrome with growth retardation; and an isolated myopathic form.

VIAS REACTOME (1)
OUTRAS DOENÇAS (1)
encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome
HGNC:25302UniProt:O75208

Variantes genéticas (ClinVar)

120 variantes patogênicas registradas no ClinVar.

🧬 COQ9: NM_020312.4(COQ9):c.-14_9dup (p.Ala4fs) ()
🧬 COQ9: GRCh38/hg38 16q21(chr16:57351323-58816575)x1 ()
🧬 COQ9: NM_020312.4(COQ9):c.714dup (p.Asn239Ter) ()
🧬 COQ9: NM_020312.4(COQ9):c.776T>C (p.Met259Thr) ()
🧬 COQ9: NM_020312.4(COQ9):c.548G>T (p.Arg183Met) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 58 variantes classificadas pelo ClinVar.

38
17
3
Patogênica (65.5%)
VUS (29.3%)
Benigna (5.2%)
VARIANTES MAIS SIGNIFICATIVAS
COQ9: NM_020312.4(COQ9):c.55C>T (p.Gln19Ter) [Pathogenic]
COQ9: NM_020312.4(COQ9):c.242+2T>G [Likely pathogenic]
COQ9: NM_020312.4(COQ9):c.262G>T (p.Glu88Ter) [Pathogenic]
COQ9: NM_020312.4(COQ9):c.711+3G>C [Pathogenic]
COQ9: NM_020312.4(COQ9):c.157C>T (p.Gln53Ter) [Pathogenic]

Vias biológicas (Reactome)

1 via biológica associada aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico2
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 2 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de encefalopatia-miocardiopatia hipertrófica-doença tubular renal

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

0 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Tubular Damage Biomarkers Are a Useful Tool for Identifying Early Renal Injury in Long COVID.

International journal of molecular sciences2026 Mar 06

Patients without overt glomerular dysfunction may develop tubular injury, referred to as subclinical acute kidney injury. The burden of COVID-19-related renal damage may therefore be underestimated, as current KDIGO criteria do not include tubular damage biomarkers (TDBs). This study evaluated kidney injury in patients with long COVID by assessing TDBs alongside glomerular biomarkers, proteinuria (UPCr) and albuminuria (UACr). In this cross-sectional study, 75 patients without prior chronic kidney disease were recruited from a long COVID outpatient clinic and stratified according to the time since SARS-CoV-2 infection into 6-, 12-, and 24-month post-COVID-19 groups (referred to as 6-, 12-, and 24-MPC, respectively). Overall, 49.3% of patients had normal estimated glomerular filtration rate (eGFR >90 mL/min/1.73 m2), 34.7% showed mildly reduced eGFR (90-60), and 16% exhibited marked eGFR reduction (<60). Among patients with normal eGFR, the combined mean prevalence (mean ± SD) of abnormal TDBs, UACr, and UPCr was 29.7 ± 4.9%, indicating early tubular injury. Temporal analysis revealed a higher prevalence of TDB abnormalities at 6-MPC, whereas glomerular dysfunction was more pronounced at 24-MPC. These findings suggest that renal injury in long COVID is more prevalent than previously recognized and that TDB assessment may improve early detection of kidney damage.

#2

Refractory Rickets: Evaluation and Management.

Indian journal of pediatrics2026 Feb 26

Refractory rickets refers to a set of diseases which are identified by a lack of response to therapeutic doses used to treat vitamin D deficiency. A child presenting with refractory rickets can pose a diagnostic dilemma as many kidney diseases have been identified as possible causes. Inherited (e.g., distal renal tubular acidosis, Fanconi syndrome, hypophosphatemic rickets, vitamin D-dependent rickets, nephronophthisis) and acquired tubular disorders [e.g., posterior urethral valves, reflux nephropathy leading to chronic kidney disease (CKD)-mineral bone disorder] may be complicated by refractory rickets. Rarely, chronic liver disease and malabsorption states can also result in refractory rickets. Hypophosphatemia is a feature of both calcipenic as well as phosphopenic rickets. Common features accompanying refractory rickets include polyuria, polydipsia, hypokalemic paralysis, fractures, limb deformities, failure-to-thrive, short-stature, tetany and nephrocalcinosis. A careful history, examination and biochemical evaluation is required to delineate the underlying cause. Using a rational algorithmic approach, it is possible to determine the correct diagnosis in these cases. Consequent upon easy availability of next generation sequencing (NGS), the accurate diagnoses can be promptly made aiding in targeted therapy. Children with refractory rickets need regular follow-up to optimise the biochemical abnormalities, monitor growth and retard the progression of CKD. This article describes the evaluation of a child with refractory rickets using an algorithmic approach, underscores the importance of the necessary blood and urine biochemical tests as well as NGS for identification of the precise etiology of refractory-rickets; and discusses the pathophysiology and management of the most important causes of refractory-rickets.

#3

Metabolic acidosis causes a Fanconi-like syndrome with intracellular trafficking defects and proximal tubule dysfunction.

Science translational medicine2026 Feb 11

Patients suffering from distal renal tubular acidosis (dRTA) are sometimes diagnosed with proximal tubule dysfunction with leaks of phosphate, uric acid, amino acids, and low-molecular weight proteins, a condition also known as Fanconi-like syndrome. The underlying molecular basis is largely elusive. We previously reported on ATPase H+ transporting V0 subunit a4 (Atp6v0a4) knockout (KO) mice, which exhibit severe metabolic acidosis in combination with proximal tubule dysfunction as evidenced by phosphaturia and proteinuria. Here, we show that ras analog in brain 7 (Rab7), a key regulator of endolysosomal trafficking and lysosomal biogenesis, was diminished, and the number of abnormal lysosomal-associated membrane protein 1 (Lamp1)-positive vesicles labeled for increased sodium tolerance 1 (Ist1) was increased in proximal tubules of Atp6v0a4 KO mice. This was accompanied by the accumulation of autophagosomes, autolysosomes, and autophagic substrates. Correction of metabolic acidosis with bicarbonate therapy resolved proximal tubule dysfunction and trafficking defects in Atp6v0a4 KO mice. After 28 days of acid challenge, wild-type mice showed comparable trafficking defects to Rab7 down-regulation and an increase in Ist1-labeled Lamp1-positive vesicles and proximal tubule damage. Acidosis-induced decreases in RAB7-labeled particles and increased numbers of IST1-labeled LAMP1-positive particles also occurred in proximal tubule correlates of human kidney organoids derived from the widely used induced pluripotent stem cell line KOLF2.1J. Together, our data provide insight into why patients suffering from severe dRTA can develop a Fanconi-like syndrome, which may contribute to the progression of chronic kidney failure.

#4

Diabetic Kidney Disease: From Pathophysiology to Treatment Perspectives.

Kidney &amp; blood pressure research2026

Chronic kidney disease (CKD) presents an extensive healthcare burden globally. Diabetes mellitus (DM) is the most prevalent cause of CKD and end-stage kidney disease, requiring renal replacement therapy. Type II DM remains the most prevalent subtype, as it is closely related to metabolic syndrome, whose prevalence is also rising with a sedentary lifestyle and with consumption of energy-dense, highly processed foods, including excess sodium, high-fat dairy products, added sugars, saturated fats, and processed meats. Therefore, understanding the pathophysiology of diabetic kidney disease (DKD), its early recognition and early initiation of the currently available therapy remains an important measure to slow the progression of the disease. Pathophysiology of DKD is a complex process, where all the mechanisms are still being elucidated on preclinical animal and in vitro models as well as in clinical studies. Changes in glomerular hemodynamics, glomerular and tubular hypertrophy, hyperfiltration, overactivation of the renin-angiotensin-aldosterone system, podocyte injury, inflammation, oxidative stress, renal hypoxia, mitochondrial injury, and epigenetic changes are the main mechanisms leading to albuminuria, glomerulosclerosis, and fibrosis. In the latter years, the importance of gut microbiota in DKD has also been shown. Understanding the mechanisms behind DKD is important, especially for researching current and possibly future pharmacological treatment of DKD. While angiotensin convertase enzyme inhibitors and angiotensin receptor blockers alongside nonpharmacological measures have been the pillars of DKD treatment and reduction of albuminuria for many decades, novel pharmacological agents are emerging, starting with sodium-glucose transporter 2 (SGLT2) inhibitors, which have been proven to affect many of the pathophysiological mechanisms, continuing with novel non-steroidal mineralocorticoid receptor antagonists, which are a new anti-inflammatory and antifibrotic possibility, and finishing with glucagon-like peptide 1 receptor antagonists (GLP1RAs), which have recently joined the therapeutic options for DKD. This comprehensive review focuses on the main pathophysiological mechanisms of DKD and current available pharmacological and non-pharmacological possibilities.

#5

Clinical diagnosis and biomarkers of acute kidney injury in liver cirrhosis: a systematic review.

Therapeutic advances in gastroenterology2026

Acute kidney injury (AKI) in cirrhotic patients is associated with high morbidity and mortality. Serum creatinine (sCr) has limited utility for early detection and etiological differentiation. Novel biomarkers and predictive models offer potential to address these limitations. To comprehensively evaluate the diagnostic performance of novel biomarkers and predictive models for the early detection and etiological differentiation of AKI in patients with liver cirrhosis. Systematic review conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses. A comprehensive literature search was performed in PubMed/Medline, EMBASE, and the Cochrane Library from inception to August 31, 2025. Studies evaluating biomarkers or models for AKI prediction or phenotyping in adult cirrhotic patients were included. Study selection, data extraction, and quality assessment (using Quality Assessment of Diagnostic Accuracy Studies-2, QUADAS-2) were performed independently by reviewers. A total of 33 studies were included. For the early prediction of AKI, serum cystatin C (Cys C) demonstrated superior performance to sCr, with an area under the receiver operating characteristic curve (AUROC) of up to 0.85. Urinary neutrophil gelatinase-associated lipocalin (NGAL) exhibited strong predictive capability and was most reliable in differentiating acute tubular necrosis from hepatorenal syndrome (HRS), achieving an AUROC up to 0.87. In contrast, kidney injury molecule-1, interleukin-18, and liver-type fatty acid binding protein, showed only moderate or inconsistent performance across most studies. Seven studies developed predictive models by integrating clinical variables with biomarkers, some of which employed machine learning techniques. However, the clinical applicability of these models is currently constrained by significant heterogeneity and limited external validation. Serum Cys C and urinary NGAL offer distinct advantages over sCr in the early diagnosis and phenotypic differentiation of AKI. Although prediction models show promise, their routine clinical application requires further standardization and extensive external validation. PROSPERO (CRD420251126410).

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 200

2026

Cystinosin regulates Na+/H+ exchanger 3 trafficking and function in kidney proximal tubular cells.

EMBO reports
2026

Increased Urinary Albumin Excretion But Less Damaged Renal Tubular Structures in Mice with Genetically Decreased Elmo1 Post Ischemia/Reperfusion Injury.

Innovation discovery
2026

Tubular Damage Biomarkers Are a Useful Tool for Identifying Early Renal Injury in Long COVID.

International journal of molecular sciences
2026

Integration of histopathology and molecular tools in shrimp health surveillance: A case study from Colombia.

Journal of aquatic animal health
2026

Kidney pathology findings in pediatric patients with kidney injury and inflammatory bowel disease: a case series.

Pediatric nephrology (Berlin, Germany)
2026

Renal Venous Hypertension and Kidney Dysfunction: Implications for Clinical Practice.

Cardiology in review
2026

Glycogen storage disease type Ia with a 17-year history of renal involvement: a case report.

Journal of medical case reports
2026

STING1 exacerbates iodinated contrast-induced acute kidney injury by promoting ferroptosis through chaperone-mediated autophagic degradation of FTH1.

Autophagy
2026

Epizootic Haemorrhagic Disease Virus (EHDV) Infection in Red Deer (Cervus elaphus), Fallow Deer (Dama dama) and Mouflon (Ovis orientalis musimon) in South-Eastern Spain: Implications for Wildlife Health and Ruminant Disease Ecology.

Animals : an open access journal from MDPI
2026

Refractory Rickets: Evaluation and Management.

Indian journal of pediatrics
2026

Voclosporin ameliorates proteinuria in a model of non-inflammatory glomerular disease.

BMC nephrology
2026

The Pathophysiological Mechanism of Beni-koji Choleste-Help or Puberulic Acid-Induced Kidney Injury.

Kidney international reports
2026

PHLDA1 is a shared diagnostic and key mediator of inflammatory fibrosis in heart and kidney.

Frontiers in immunology
2026

Secukinumab: A new Hope for precision treatment of Acute kidney injury.

Biochemical pharmacology
2026

Outcomes and predictors of kidney failure in elderly patients with biopsy-proven IgA nephropathy.

Renal failure
2026

Tubular EZH2 promotes acute kidney injury by Inhibiting SDHC-mediated mitochondrial function.

Free radical biology &amp; medicine
2026

Clinicopathologic Features and Prognostic Factors in Biopsy-Confirmed Renal Involvement in Primary Sjőgren's Syndrome.

Kidney360
2026

FSTIV score is essential for clinical management and predicts outcome of idiopathic membranous nephropathy.

BMC nephrology
2026

Metabolic acidosis causes a Fanconi-like syndrome with intracellular trafficking defects and proximal tubule dysfunction.

Science translational medicine
2026

From Breast Mass to Paralysis: Lymphocytic Mastitis as the Sentinel Manifestation of Sjögren's Syndrome.

European journal of case reports in internal medicine
2026

Glomerular Transcriptome Analysis Reveals Endothelial Disturbances in Patients With Idiopathic Nephrotic Syndrome.

Kidney medicine
2026

The triglyceride-glucose index as an independent associate of severe tubulointerstitial fibrosis and a predictor of renal survival in IgA nephropathy.

Frontiers in endocrinology
2025

LncRNA AK154753 mediates the development of acute kidney ischemia reperfusion injury via the miR-345-3p/Bak and miR-708-5p/Bim pathways.

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
2026

Targeting RIG-I alleviates renal tubular epithelial cells PANoptosis during post-traumatic rhabdomyolysis.

Translational research : the journal of laboratory and clinical medicine
2026

Early-onset kidney failure in a girl with autosomal dominant tubulointerstitial kidney disease due to a de novo UMOD variant.

CEN case reports
2026

C3 glomerulonephritis with light chain crystalline podocytopathy and non-crystalline proximal tubulopathy: a case report and integrative clinicopathologic analysis.

BMC nephrology
2026

Diabetic Kidney Disease: From Pathophysiology to Treatment Perspectives.

Kidney &amp; blood pressure research
2026

Clinical diagnosis and biomarkers of acute kidney injury in liver cirrhosis: a systematic review.

Therapeutic advances in gastroenterology
2026

An Extremely Low-Birth-Weight Infant With Bone Fragility Due to Fanconi Syndrome.

Kidney medicine
2026

Fibrillary Light Chain Proximal Tubulopathy: A Distinct Subtype Within the Spectrum of Light Chain Proximal Tubulopathy.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2026

Histopathological evaluation in post-mortem renal biopsies of patients with COVID-19 and comorbidities: a case-control study.

Sao Paulo medical journal = Revista paulista de medicina
2025

Primary Sjögren's Syndrome Presenting With Severe Hypokalemia Due to Distal Renal Tubular Acidosis: A Case Report.

Cureus
2026

Gender-Based Analysis of Perioperative and Early Postoperative Complications in Tubular Microdiscectomy for Lumbar Disc Prolapse: A Retrospective Comparative Study.

Health science reports
2026

Chronic Kidney Disease in Metabolic Disease: Regulation of SGLT2 and Transcriptomic-Epigenetic Effects of Its Pharmacological Inhibition.

International journal of molecular sciences
2026

Protective Effects of Oxyberberine Against Hyperuricemic Nephropathy: Mechanistic Insights From In Silico, In Vitro, and In Vivo Studies.

Phytotherapy research : PTR
2026

Clinical and molecular characteristics of constitutional mismatch repair deficiency syndrome: a case series of five children and appraisal of diagnostic guidelines.

Diagnostic pathology
2026

Tubulointerstitial nephritis with uveitis (TINU) syndrome following COVID-19 vaccination in an elderly patient: a case report.

CEN case reports
2025

Diuretic resistance in cardiorenal syndrome: mechanisms, monitoring and phenotype-tailored management.

Frontiers in cardiovascular medicine
2026

Hypercalcemia of malignancy in a dog with cutaneous apocrine gland carcinoma and malignant myoepithelioma.

Veterinary research communications
2026

Effects of <sc>n</sc>-Acetyl-<sc>l</sc>-Cysteine on the Progression of Kidney Dysfunction in Acadian Variant Fanconi Syndrome: A Case Series.

Nephron
2026

Neural Upregulation of SGLT2-MAP17-PDZK1 Complex in Kidneys of Rats With Heart Failure.

Hypertension (Dallas, Tex. : 1979)
2026

Cell membrane-coated nanoparticles target multiorgan crosstalk in cardiovascular-kidney-metabolic syndrome.

Acta biomaterialia
2026

Targeting Hypercalciuria in SLC34A1-Related Disorders: Impact of Oral Phosphate Therapy and Novel Genetic Insights in Pediatric Case Series.

Calcified tissue international
2026

Biomarkers in Cardiorenal Syndrome: Focus on Type 1.

Internal medicine (Tokyo, Japan)
2026

Alport Syndrome is a Partial Tubulointerstitial Disease of the Kidney.

Kidney international reports
2026

Burosumab treatment for FGF23-related hypophosphatemia in a two-year-old girl with McCune-Albright syndrome.

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology
2026

HELIX syndrome in childhood. A claudinopathy with a salt-wasting tubulopathy phenotype with hypermagnesemia.

Nefrologia
2025

Complicated Pregnancy in a Patient with Distal Renal Tubular Acidosis, Systemic Lupus Erythematosus, and Antiphospholipid Syndrome: A Rare Case and Management Strategies.

Acta medica Indonesiana
2026

Icariin sensitizes glucocorticoid therapy in doxorubicin-induced fibrotic nephrotic syndrome via the HIF-1α/NF-κB/HDAC2 Axis.

International immunopharmacology
2026

Dapagliflozin Reduces Kidney Inflammation in Alport Syndrome by Inhibiting the Stimulator of Interferon Genes Pathway in Renal Tubular Epithelial Cells.

Kidney360
2026

Innovative integration of plant photosynthetic system for targeted restoration of NAD+/NADPH imbalance in acute kidney injury.

Journal of materials chemistry. B
2026

Lycopene protects against acute kidney injury by suppressing PARP/NOTCH-mediated inflammation.

International immunopharmacology
2026

Dual-Genetic Etiology in an Atypical Dent Disease Phenotype Which Combines Features of Focal Segmental Glomerulosclerosis and Ellis-Van Creveld-Like Syndrome: A Case Report.

Case reports in nephrology and dialysis
2025

Acute kidney injury associated with acute fatty liver of pregnancy: An update on a rare clinical entity.

World journal of nephrology
2025

Endothelial defects unveil cardiovascular phenotype in iPSC-based disease modelling across three generations of a DiGeorge syndrome family.

Research square
2025

Primary Sjögren's Syndrome Presenting With Hypokalemic Rhabdomyolysis, Distal Renal Tubular Acidosis, and Fulminant Necrotizing Vasculitis: A Case Report.

Cureus
2026

Elucidating the therapeutic mechanism of Orthosiphon aristatus in hyperuricemic nephropathy: An integrated microbiome-metabolomics approach.

Journal of ethnopharmacology
2025

When teeth and kidneys fail together: a case series of amelogenesis imperfecta-renal syndromes in childhood.

The Pan African medical journal
2025

Tubular Biomarkers and Retinal Microvasculature: Illuminating Early Cardiovascular-Kidney-Metabolic Pathways Beyond the Glomerulus.

Kidney360
2025

The Red Herring Cast: Interstitial Nephritis in Disguise.

Cureus
2025

Randomized controlled clinical trial of Shenzhuo Formula in the treatment of macroalbuminuria in diabetic kidney disease and its inflammation-modulating mechanisms.

Precision clinical medicine
2025

Enterohemorrhagic Escherichia coli O157 outer membrane vesicles administered by oral gavage cause renal tubular injury and acute kidney failure in mice.

Frontiers in cellular and infection microbiology
2025

Bridging Cardiorenal and Hepatic Disease: The Emerging Role of SGLT2 Inhibitors in Cirrhosis.

Cardiology in review
2026

Thrombomodulin protects against acute vascular and multiorgan injury in sickle cell disease.

JCI insight
2025

Mitochondrial structure and function in OCRL depleted cells.

Frontiers in cell and developmental biology
2026

ROS-responsive cellular vesicles with ferroptosis-targeting siACMSD delivery for acute kidney injury therapy.

Theranostics
2026

Therapeutic potential of tanshinone IIA in folic acid-induced acute kidney injury: a network pharmacology approach.

Biotechnic &amp; histochemistry : official publication of the Biological Stain Commission
2025

Novel urinary biomarkers to differentiate AKI etiologies and predict mortality in decompensated cirrhosis patients: a prospective cohort study.

BMC gastroenterology
2026

Multimodal mechanisms of di (2-ethylhexyl) phthalate-induced cardiovascular-kidney-metabolic syndrome: Integrating epidemiology, network toxicology and experimental validation.

Ecotoxicology and environmental safety
2026

Exploring the gut-kidney axis: Berberine's role in alleviating chronic kidney disease through microbiota and short-chain fatty acids.

Journal of ethnopharmacology
2026

Exome Sequencing in a Large Cohort with Ciliopathy-Related Kidney Disease.

Clinical journal of the American Society of Nephrology : CJASN
2025

A Rare Triad of Type 1 Distal Renal Tubular Acidosis, Cryptogenic Multifocal Ulcerous Stenosing Enteritis, and Superior Mesenteric Artery Syndrome in a Young Adult.

Cureus
2025

Multiple Unilateral Subcapsular Cortical Hemorrhagic Cystic in the Left Kidney Disease: A Case Report of a Potential New Clinical Entity in Young Adults.

Case reports in nephrology and dialysis
2025

Senior-Løken syndrome with IQCB1/NPHP5 mutation in an adult: a case report.

Journal of medical case reports
2026

Discovery Pipeline for Acute Kidney Injury: Molecules, Mechanisms, Models, and Targets.

Nephron
2025

Anti-nephrin antibodies in minimal change disease: Case report series.

Clinical nephrology
2025

The Kidney in the Shadow of Cirrhosis: A Critical Review of Renal Failure.

Biomedicines
2025

Genomics and Multi-Omics Perspectives on the Pathogenesis of Cardiorenal Syndrome.

Genes
2025

Exploring Etiologies of Hypokalemic Paralysis: A Case Series.

The Journal of the Association of Physicians of India
2025

Podocyte specific exon skipping after disease onset improves kidney pathology and function in a mouse model of Alport syndrome.

Scientific reports
2025

Genetic etiology of inherited kidney diseases in egyptian patients: next generation sequencing identifies six novel variants.

Molecular and cellular pediatrics
2025

The Rare Occurrence of Tissue PLA2R-Positive Membranous Nephropathy in a Patient With Sjögren's Syndrome and Renal Tubular Acidosis.

British journal of hospital medicine (London, England : 2005)
2025

Hepatitis-hydropericardium syndrome in native chickens: A clinicopathological study.

Iranian journal of veterinary research
2025

DHHC21 is a STIM1 protein S-acyltransferase that modulates immune function in vivo.

bioRxiv : the preprint server for biology
2025

Clinical Characteristics, Symptoms, and Long-Term Outcomes in Gitelman Syndrome.

Kidney international reports
2025

Acute oxalate nephropathy seven years post Roux-en-Y gastric bypass surgery without excessive vitamin C intake: a case report.

BMC geriatrics
2025

Oxalate nephropathy precipitated by linaclotide in a high-risk patient.

Clinical nephrology. Case studies
2025

Statins as Modulators of Epithelial to Mesenchymal Transition in Cardiovascular-Kidney-Metabolic Syndrome: a Comprehensive Review of Mechanisms and Therapeutic Implications.

Current atherosclerosis reports
2025

West Nile Virus Neuroinvasive Disease Presenting with Acquired Fanconi Syndrome, Which Resolved on Recovery.

European journal of case reports in internal medicine
2025

A TRIM8 Variant in a Child: Neuro-Renal Syndrome Causing Features Suggestive of Medullary Sponge Kidney.

Nephrology (Carlton, Vic.)
2025

Autophagy in the Pathogenesis of Membranous Nephropathy.

Kidney medicine
2026

Regulating the GTP cyclohydrolase 1/tetrahydrobiopterin axis in the distal tubule inhibits ferroptosis and alleviates crush syndrome-related acute kidney injury in mice.

Cellular signalling
2025

Modelling CubAm function and regulation in proximal tubular cells using iPSC-derived kidney organoids.

Experimental cell research
2026

Mouse Alport podocytes are susceptible to AAV9 transduction in vivo.

Kidney international
2026

Drug repurposing in PIK3CA-related overgrowth spectrum: breakthroughs from overgrowth syndromes to kidney disease.

Kidney international
2025

The association between CKD and frailty in the FRASNET study: suggestion of a novel eGFR threshold as a key determinant of frailty in the elderly.

Journal of nephrology
2025

The Emerging Role of Magnesium in Preventing Acute Kidney Disease During Concurrent Chemoradiotherapy in Head and Neck Cancer.

Cancers
2025

Description of the Distinctive Changes in the Colonic Microbiome Associated with Irritable Bowel Syndrome, Uncomplicated Diverticulitis, and Tubular Adenoma.

Biomedicines
2025

Vitamin D receptor modulates autophagy via miR-20a-5p/ATG16L1 axis to alleviate lipopolysaccharide-induced acute kidney injury.

Renal failure
2025

Severe Hypokalemic Paralysis Unmasking Renal Tubular Acidosis in a Patient With Sjögren's Syndrome.

Cureus
2025

Late-Onset Lupus Nephritis: Clinical-Epidemiological, Histological, Prognostic, and Therapeutic Implications: A Single-Center Experience from Northeastern Spain.

Glomerular diseases
2025

Bupi Yishen formula against chronic kidney injury via Akkermansia muciniphila mediated group 3 innate lymphoid cells activation to repair intestinal barrier funciton.

Phytomedicine : international journal of phytotherapy and phytopharmacology
2025

Isolated dyslipidemia triggers early kidney injury through fibrotic remodeling, subcellular lipid accumulation, and AMPK overexpression.

Ultrastructural pathology
2026

Electrophoretic patterns of proteinuria in dogs with Cushing's syndrome.

The Journal of small animal practice
2025

BMAL1 alleviates sepsis-induced acute kidney injury by inhibiting apoptosis, ferroptosis and inflammation.

Hereditas
2026

A Murine Model of Cardiovascular-Kidney-Metabolic Syndrome Demonstrates Compromised Limb Function in the Ischemic Hind Limb.

Kidney360
2025

SPP1 as a biomarker for idiopathic membranous nephropathy progression and its regulatory role in inflammation and fibrosis.

Frontiers in immunology
2026

Reticulon 3 deficiency induces ferroptosis via chaperone-mediated autophagy in ischemia-reperfusion induced acute kidney injury.

Free radical biology &amp; medicine
2025

The spectrum of neuromuscular diseases with tubular aggregates.

Neuromuscular disorders : NMD
2025

Calcific Changes in an End-Stage Kidney following Long-Term Dialysis, Tertiary Hyperparathyroidism, and Treatment for Complement-Mediated Thrombotic Microangiopathy: A Case Report.

Glomerular diseases
2025

Prospective evaluation of CAR-T cell therapy-related proteinuria and kidney dysfunction.

Clinical kidney journal
2025

Association Between Urinary Fractional Excretion of Potassium and Proteinuria Remission in Adult Nephrotic Syndrome.

Kidney360
2025

Effect of 2-Hydroxypropyl-γ-cyclodextrin on Renal Inflammation in Alport Mouse Model.

Biological &amp; pharmaceutical bulletin
2025

Store-operated calcium entry-based targets for novel cancer therapeutic development.

The Journal of pharmacology and experimental therapeutics
2025

Case Report: A rare case of complex Behçet's disease complicated with acute tubular necrosis and IgA nephropathy, coexists with myelodysplastic syndrome, trisomy 8 and intestinal involvement.

Frontiers in immunology
2025

The challenges of managing distal renal tubular acidosis in pregnant patients with primary Sjögren's disease.

BMJ case reports
2026

Novel CNNM2 variant causing hypomagnesemia and early-onset calcium pyrophosphate deposition disease: A case report.

Joint bone spine
2025

Multidisciplinary Management and Individualized Care in Pregnancy with Fanconi-Bickel Syndrome: A Case Report and Review of the Literature.

International medical case reports journal
2025

Potential of Orally Administered Quercetin, Hesperidin, and p-Coumaric Acid in Suppressing Intra-/Extracellular Advanced Glycation End-Product-Induced Cytotoxicity in Proximal Tubular Epithelial Cells.

International journal of molecular sciences
2025

HEC95468, a novel soluble guanylate cyclase stimulator, shows protection in the Dahl model of cardiorenal disorder.

European journal of pharmacology
2025

Novel Scalar-on-matrix Regression for Unbalanced Feature Matrices.

Statistics in biosciences
2026

Urine-to-blood urea nitrogen ratio predicts proteinuria remission in nephrotic syndrome.

Clinical and experimental nephrology
2025

Underlying metabolic syndrome exacerbates Vibrio vulnificus-induced acute kidney injury via systemic Th17/Treg dysregulation.

American journal of physiology. Renal physiology
2025

Concordant X-linked hypophosphatemic rickets in monozygotic twins: diagnostic challenges and a novel genetic insight.

Endocrinology, diabetes &amp; metabolism case reports
2025

Acute kidney injury and nephrotic syndrome caused by a "magic pill".

Clinical nephrology. Case studies
2025

Citrate and calcium kidney stones.

Clinical kidney journal
2025

Current epidemiological overview of glomerulonephritis in Latin America: a systematic literature review.

Journal of nephrology
2025

Kidney Tubule Secretion Can Discriminate the Cause of Acute Kidney Injury in Cirrhosis.

Clinical journal of the American Society of Nephrology : CJASN
2025

A Novel Mutation of Fanconi-Bickel Syndrome: A Case Report.

The Journal of the Association of Physicians of India
2025

Tubular ACSM3 deficiency impairs medium-chain fatty acid metabolism and aggravates kidney fibrosis.

Proceedings of the National Academy of Sciences of the United States of America
2025

Multiple Myeloma With Renal Pathological Findings of Both Light Chain-Only Variant of Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits (PGNMID-LC) and Light Chain Deposition Disease (LCDD).

Cureus
2025

Acute Drug-Induced Tubulointerstitial Nephritis: Current Perspectives on Diagnosis and Treatment.

Advances in kidney disease and health
2025

Novel Pathogenic Genotype in SLC12A3 Associated to Gitelman Syndrome: A Case Report.

Nephrology (Carlton, Vic.)
2025

LRP5: A Multifaceted Co-Receptor in Development, Disease, and Therapeutic Target.

Cells
2026

Real-World Use of Terlipressin in Cirrhosis and Acute Kidney Injury: Frequent Use Beyond Hepatorenal Syndrome.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
2025

CRISPR and gene editing for kidney diseases: where are we?

Clinical kidney journal
2026

Copeptin in the diagnosis and management of renal tubular disorders.

Pediatric nephrology (Berlin, Germany)
2025

Evaluation of Serum Levels of Kidney Injury Molecule-1 (KIM-1) and Neutrophil Gelatinase-Associated Lipocalin (NGAL) as Potential Biomarkers of Renal Tubular Damage in Brucellosis Patients.

International journal of general medicine
2025

Reduced TIGIT+CD56+NK cells associate with disease progression and impaired immune regulation in primary Sjögren's syndrome.

Clinical rheumatology
2025

Fatigue, Polyuria, and Hidden Uveitis: A Case of Tubulointerstitial Nephritis and Uveitis Syndrome Diagnosed in Primary Care.

Cureus
2025

Silencing RPL11 attenuates acute kidney injury by suppressing tubular apoptosis and macrophage-driven inflammation.

Frontiers in immunology
2025

Hypokalemic Periodic Paralysis in a Patient With Primary Sjögren's Syndrome and Distal Renal Tubular Acidosis: A Case Report.

Clinical medicine insights. Case reports
2025

Pseudohypoparathyroidism type 1B mimicking gitelman syndrome: diagnostic pitfalls and molecular insights.

Frontiers in genetics
2025

Acute Kidney Injury in Patients with Liver Cirrhosis: From Past to Present Definition and Diagnosis.

Life (Basel, Switzerland)
2025

Bilateral, multicystic fumarate hydratase-deficient renal cell carcinoma in patient with hereditary leiomyomatosis & renal cell carcinoma syndrome: A case report and review of the literature.

Diagnostic pathology
2025

Use of urinary NGAL in steroid-resistant vs. steroid-sensitive nephrotic syndrome: a systematic review and meta-analysis.

BMC nephrology
2025

Mitochondrial dysfunction and metabolic reprogramming in acute kidney injury: mechanisms, therapeutic advances, and clinical challenges.

Frontiers in physiology
2025

FGF4 alleviates renal injury caused by ischemia-reperfusion(I/R) by inhibiting ferroptosis and pyroptosis.

Peptides
2025

Analysis of pathological spectrum characteristics in elderly patients with nephrotic syndrome: a comparative study with non-elderly patients.

Renal failure
2025

Hereditary distal renal tubular acidosis with chronic granulomatous disease: a rare coincidence.

CEN case reports
2025

Modelling Lowe syndrome and Dent-2 disease using zebrafish.

Frontiers in cell and developmental biology
2025

Chronic ACTH Infusion Alters the Diurnal Rhythm of Sodium Excretion, Inducing Nondipping Blood Pressure and Salt-Sensitivity in Male Mice.

Hypertension (Dallas, Tex. : 1979)
2025

Comprehensive mutational characterization of the calcium-sensing STIM1 EF-hand reveals residues essential for structure and function.

Genetics
2025

Renal Vein Blood Flow Patterns Identify Patients at Risk for Early Kidney Allograft Loss Due to Cardiac Postrenal Vein Congestion.

Journal of clinical medicine
2026

Keratin 20 Suppresses Exosomal Secretion of Peroxiredoxin 2 and Ferroptosis in Acute Kidney Injury.

Journal of the American Society of Nephrology : JASN
2025

DNAJC6 in acute kidney injury: A novel target for protecting renal tubular epithelial cells through PGC-1α-mediated mitochondrial homeostasis.

Experimental cell research
2025

Renal Involvement in Primary Sjögren's Syndrome: A Multi-centric Study From North India.

Cureus
2025

A case of adult-onset Bartter syndrome with transient paraplegia.

Oxford medical case reports
2024

Sjogren's Syndrome in the Mask of Hypokalemia: A Case Report.

JNMA; journal of the Nepal Medical Association
2025

Kidney melanosis associated with a novel HSP-1 Hermansky-Pudlak oculocutaneous albinism mutation: a case report.

BMC nephrology
2025

Craniometaphyseal dysplasia leading to hydrocephalus and Chiari I malformation.

BMJ case reports
2025

A rare concurrence of monoclonal gammopathies in an older adult with tubulointerstitial nephritis and uveitis syndrome.

BMC geriatrics
2025

Systemic immune-inflammatory biomarkers assist in differentiating clinical features of different etiologies of acute kidney injury: results from eICU Collaborative Research Database.

Renal failure
2025

The effect of carvacrol on kidney injury caused by isopreterenol-induced myocardial infarction.

BMC nephrology
2025

Injured tubule derived CCN1 exacerbates renal congestion-mediated acute kidney injury and fibrosis.

Scientific reports
2025

Hesperetin attenuates ischemia/reperfusion-induced acute kidney injury by regulating ferroptosis in mice.

Renal failure
2025

Aberrant activation of IL-6/JAK/STAT3/FOSL1 signaling induces renal abnormalities in a Xenopus model of Joubert syndrome-related disorders.

The Journal of biological chemistry
2025

Renal tubular acidosis: Varied aetiologies and clinical presentations: Three case reports.

World journal of nephrology
2025

An Atypical Case of Sjögren's Syndrome: A Surprise Diagnosis.

Cureus
2025

Hemoglobin-associated CALR in proximal tubule cells can be used as a biomarker for idiopathic membranous nephropathy.

Frontiers in medicine
2025

New and Emerging Biomarkers in Chronic Kidney Disease.

Biomedicines
2025

Transcriptomic Redox Dysregulation in a Rat Model of Metabolic Syndrome-Associated Kidney Injury.

Antioxidants (Basel, Switzerland)
2025

Acute kidney injury through a metabolic lens: pathological reprogramming mechanisms and clinical translation potential.

Frontiers in physiology
2025

Cardiac LIM Protein, Kidney Fibrosis, and Vascular Change after Acute Cardiorenal Syndrome.

Journal of the American Society of Nephrology : JASN
2026

Identifying the Fourth Patient With Spastic Paraplegia 90, Extending the Phenotype Spectrum.

Clinical genetics
2025

Zhen-wu-tang alleviates nephrotic syndrome by upregulating 5-HTR1B to activate AMPK/PGC-1α-mediated mitochondrial biogenesis.

Journal of ethnopharmacology
2025

Succinate links TCA cycle dysfunction to inflammation by activating HIF-1α signaling in acute kidney injury.

International immunopharmacology
2025

Efficacy of Nrf2 activation in a proteinuric Alport syndrome mouse model.

Life science alliance
2025

Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Biomarker of Acute Kidney Injury (AKI) in Dogs with Congestive Heart Failure (CHF) Due to Myxomatous Mitral Valve Disease (MMVD).

Animals : an open access journal from MDPI
2025

Latent renal tubular dysfunction in patients with epilepsy treated with valproic acid.

Epilepsy research
2025

Nephronophthisis and Retinitis Pigmentosa (Senior-Loken Syndrome) After Living-Donor Kidney Transplantation: Twelve-Year Follow-Up in a Young Woman.

Journal of medical cases
2026

Renal replacement therapy in liver transplant-ineligible patients.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
2025

The Diagnosis and Management of Hepatorenal Syndrome: A Comprehensive Update for the Intensivist.

Journal of intensive care medicine
2025

Mito-tempo ameliorates tubular injury of diabetic nephropathy via inhibiting mt-dsRNA release and PKR/eIF2α pathway activation.

Free radical biology &amp; medicine
2025

The enzyme SMPDL3b in podocytes decouples proteinuria from chronic kidney disease progression in experimental Alport Syndrome.

Kidney international
2025

TRPC6-targeted dexamethasone nanobubbles with ultrasound-guided theranostics for adriamycin-induced nephropathy.

Journal of nanobiotechnology
2025

Valacyclovir-induced neurotoxicity and nephrotoxicity in an elderly patient with a history of nephrectomy: a case report.

BMC nephrology
2025

A cohort of GFPT1 related congenital myasthenic syndrome in China: high frequency of c.331 c > t variant.

Orphanet journal of rare diseases
2025

Gitelman syndrome with hypercalcemia and normomagnesemia: A case report.

Medicine
2025

Crescentic Glomerulonephritis Possibly Caused by COVID-19 Infection.

Journal of clinical medicine
2025

Phenotypes and the Importance of Genetic Analysis in Adult Patients with Nephrolithiasis and/or Nephrocalcinosis: A Single-Center Experience.

Genes
2025

From prenatal detection to postnatal evaluation: a retrospective observational ultrasound study of patent urachus with allantoic cyst.

BMC pregnancy and childbirth
2025

Hypertensive Emergency and Atypical Hemolytic Uremic Syndrome Associated with Cocaine Use: A Diagnostic and Therapeutic Challenge.

Diseases (Basel, Switzerland)
2025

Cockayne syndrome mice reflect human kidney disease and are defective in de novo NAD biosynthesis.

Cell death and differentiation
2026

Long-term outcomes in nephropathic cystinosis: a review.

Pediatric nephrology (Berlin, Germany)
2025

Genome sequencing identifies RMND1 as a strong candidate gene for severe prenatal kidney failure mimicking renal tubular dysgenesis associated with hyporeninism.

Pediatric nephrology (Berlin, Germany)
2025

Multicentric B-cell lymphoma, phaeochromocytoma and amyloid-rich thyroid carcinoma in a common warthog (Phacochoerus africanus): a case of multiple endocrine neoplasia type 2?

Journal of comparative pathology
2025

Integral kidney function assessment in pediatric patients with glycogen storage diseases.

Frontiers in pediatrics
2025

Targeting Stat3 with conditional knockout or PROTAC technology alleviates renal injury by Limiting pyroptosis.

EBioMedicine
2025

Clerodendranthus spicatus-Cordyceps cicadae regulates mitophagy and protects renal tubular epithelial cells from hyperuricemic nephropathy.

Journal of ethnopharmacology

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de encefalopatia-miocardiopatia hipertrófica-doença tubular renal.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de encefalopatia-miocardiopatia hipertrófica-doença tubular renal

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Tubular Damage Biomarkers Are a Useful Tool for Identifying Early Renal Injury in Long COVID.
    International journal of molecular sciences· 2026· PMID 41828637mais citado
  2. Refractory Rickets: Evaluation and Management.
    Indian journal of pediatrics· 2026· PMID 41741919mais citado
  3. Metabolic acidosis causes a Fanconi-like syndrome with intracellular trafficking defects and proximal tubule dysfunction.
    Science translational medicine· 2026· PMID 41671337mais citado
  4. Diabetic Kidney Disease: From Pathophysiology to Treatment Perspectives.
    Kidney &amp; blood pressure research· 2026· PMID 41632731mais citado
  5. Clinical diagnosis and biomarkers of acute kidney injury in liver cirrhosis: a systematic review.
    Therapeutic advances in gastroenterology· 2026· PMID 41630837mais citado
  6. Increased Urinary Albumin Excretion But Less Damaged Renal Tubular Structures in Mice with Genetically Decreased Elmo1 Post Ischemia/Reperfusion Injury.
    Innov Discov· 2026· PMID 41841030recente
  7. Integration of histopathology and molecular tools in shrimp health surveillance: A case study from Colombia.
    J Aquat Anim Health· 2026· PMID 41823880recente
  8. Kidney pathology findings in pediatric patients with kidney injury and inflammatory bowel disease: a case series.
    Pediatr Nephrol· 2026· PMID 41793461recente
  9. Renal Venous Hypertension and Kidney Dysfunction: Implications for Clinical Practice.
    Cardiol Rev· 2026· PMID 41779019recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:319678(Orphanet)
  2. OMIM OMIM:614654(OMIM)
  3. MONDO:0013840(MONDO)
  4. GARD:17470(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q60195093(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome de encefalopatia-miocardiopatia hipertrófica-doença tubular renal
Compêndio · Raras BR

Síndrome de encefalopatia-miocardiopatia hipertrófica-doença tubular renal

ORPHA:319678 · MONDO:0013840
Prevalência
<1 / 1 000 000
Casos
1 casos conhecidos
Herança
Autosomal recessive
CID-10
E88.8 · Outros distúrbios especificados do metabolismo
CID-11
Início
Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C4706367
Repurposing
1 candidato
dexrazoxanechelating agent|topoisomerase inhibitor
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades